WENTWORTH KORY JAMES 4
4 · Entrada Therapeutics, Inc. · Filed Mar 19, 2025
Insider Transaction Report
Form 4
WENTWORTH KORY JAMES
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-03-17$10.67/sh−1,784$19,035→ 109,536 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.